Prosecution Insights
Last updated: October 04, 2026

Jeneil Biosurfactant Company LLC

1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Jeneil Biosurfactant Company LLC is currently managing 1 pending office action. This single active case is assigned to 1 distinct examiner, centralizing the company's current interactions with the patent office. The busiest examiner for the company is O'HERN, BRENT T, who is responsible for 1 pending office action. This workload matches the total pending office actions for the entire portfolio.

Because the distinct examiners count is 1, there is no variation in the personnel reviewing the company's active matters. This concentration suggests that the company's current prosecution strategy is focused on the requirements of a single examiner. The progress of the portfolio is therefore dependent on the specific evaluation provided by this 1 official at the patent office. The data indicates that all active prosecution efforts are concentrated under this single point of contact.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
100% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
O'HERN, BRENT T 1 78.5% +19.8%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18769078 Antimicrobial Compositions for Modulation of Fruit and Vegetable Tissue Necrosis O'HERN, BRENT T —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18769078 Antimicrobial Compositions for Modulation of Fruit and Vegetable Tissue Necrosis O'HERN, BRENT T —

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18769078 Antimicrobial Compositions for Modulation of Fruit and Vegetable Tissue Necrosis O'HERN, BRENT T — §103§112 Non-Final OA — Pending Jul 10, 2024

Managing Jeneil Biosurfactant Company LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month